Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Nanowire forest of pnictogen-chalcogenide alloys for thermoelectricity.

Singhal D, Paterson J, Ben-Khedim M, Tainoff D, Cagnon L, Richard J, Chavez-Angel E, Fernandez JJ, Sotomayor-Torres CM, Lacroix D, Bourgault D, Buttard D, Bourgeois O.

Nanoscale. 2019 Jul 18;11(28):13423-13430. doi: 10.1039/c9nr01566c.

PMID:
31281906
2.

A robust ALD-protected silicon-based hybrid photoelectrode for hydrogen evolution under aqueous conditions.

Chandrasekaran S, Kaeffer N, Cagnon L, Aldakov D, Fize J, Nonglaton G, Baleras F, Mailley P, Artero V.

Chem Sci. 2019 Mar 12;10(16):4469-4475. doi: 10.1039/c8sc05006f. eCollection 2019 Apr 28.

3.

Emerging Opportunities of Radiotherapy Combined With Immunotherapy in the Era of Breast Cancer Heterogeneity.

Tsoutsou PG, Zaman K, Martin Lluesma S, Cagnon L, Kandalaft L, Vozenin MC.

Front Oncol. 2018 Dec 12;8:609. doi: 10.3389/fonc.2018.00609. eCollection 2018. Review.

4.

Lymphatic vessel density is associated with CD8+ T cell infiltration and immunosuppressive factors in human melanoma.

Bordry N, Broggi MAS, de Jonge K, Schaeuble K, Gannon PO, Foukas PG, Danenberg E, Romano E, Baumgaertner P, Fankhauser M, Wald N, Cagnon L, Abed-Maillard S, Maby-El Hajjami H, Murray T, Ioannidou K, Letovanec I, Yan P, Michielin O, Matter M, Swartz MA, Speiser DE.

Oncoimmunology. 2018 May 31;7(8):e1462878. doi: 10.1080/2162402X.2018.1462878. eCollection 2018.

5.

Measurement of anisotropic thermal conductivity of a dense forest of nanowires using the 3ω method.

Singhal D, Paterson J, Tainoff D, Richard J, Ben-Khedim M, Gentile P, Cagnon L, Bourgault D, Buttard D, Bourgeois O.

Rev Sci Instrum. 2018 Aug;89(8):084902. doi: 10.1063/1.5025319.

PMID:
30184711
6.

Quantification of the next-generation oral anti-tumor drugs dabrafenib, trametinib, vemurafenib, cobimetinib, pazopanib, regorafenib and two metabolites in human plasma by liquid chromatography-tandem mass spectrometry.

Cardoso E, Mercier T, Wagner AD, Homicsko K, Michielin O, Ellefsen-Lavoie K, Cagnon L, Diezi M, Buclin T, Widmer N, Csajka C, Decosterd L.

J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Apr 15;1083:124-136. doi: 10.1016/j.jchromb.2018.02.008. Epub 2018 Feb 8.

PMID:
29544202
7.

Very Late Antigen-1 Marks Functional Tumor-Resident CD8 T Cells and Correlates with Survival of Melanoma Patients.

Murray T, Fuertes Marraco SA, Baumgaertner P, Bordry N, Cagnon L, Donda A, Romero P, Verdeil G, Speiser DE.

Front Immunol. 2016 Dec 12;7:573. doi: 10.3389/fimmu.2016.00573. eCollection 2016.

8.

Rapid and Continued T-Cell Differentiation into Long-term Effector and Memory Stem Cells in Vaccinated Melanoma Patients.

Gannon PO, Baumgaertner P, Huber A, Iancu EM, Cagnon L, Abed Maillard S, Maby-El Hajjami H, Speiser DE, Rufer N.

Clin Cancer Res. 2017 Jul 1;23(13):3285-3296. doi: 10.1158/1078-0432.CCR-16-1708. Epub 2016 Nov 21.

9.

Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8+ and CD4+ T-cell responses with multiple specificities including a novel DR7-restricted epitope.

Baumgaertner P, Costa Nunes C, Cachot A, Maby-El Hajjami H, Cagnon L, Braun M, Derré L, Rivals JP, Rimoldi D, Gnjatic S, Abed Maillard S, Marcos Mondéjar P, Protti MP, Romano E, Michielin O, Romero P, Speiser DE, Jandus C.

Oncoimmunology. 2016 Sep 9;5(10):e1216290. eCollection 2016.

10.

Direct electrical transport measurement on a single thermoelectric nanowire embedded in an alumina template.

Ben Khedim M, Cagnon L, Garagnon C, Serradeil V, Bourgault D.

Phys Chem Chem Phys. 2016 Apr 28;18(17):12332-7. doi: 10.1039/c6cp00972g.

PMID:
27086560
11.

Vaccination with LAG-3Ig (IMP321) and Peptides Induces Specific CD4 and CD8 T-Cell Responses in Metastatic Melanoma Patients--Report of a Phase I/IIa Clinical Trial.

Legat A, Maby-El Hajjami H, Baumgaertner P, Cagnon L, Abed Maillard S, Geldhof C, Iancu EM, Lebon L, Guillaume P, Dojcinovic D, Michielin O, Romano E, Berthod G, Rimoldi D, Triebel F, Luescher I, Rufer N, Speiser DE.

Clin Cancer Res. 2016 Mar 15;22(6):1330-40. doi: 10.1158/1078-0432.CCR-15-1212. Epub 2015 Oct 23.

12.

Long-lasting stem cell-like memory CD8+ T cells with a naïve-like profile upon yellow fever vaccination.

Fuertes Marraco SA, Soneson C, Cagnon L, Gannon PO, Allard M, Abed Maillard S, Montandon N, Rufer N, Waldvogel S, Delorenzi M, Speiser DE.

Sci Transl Med. 2015 Apr 8;7(282):282ra48. doi: 10.1126/scitranslmed.aaa3700.

13.

Pulmonary sarcoid-like granulomatosis after multiple vaccinations of a long-term surviving patient with metastatic melanoma.

Bordry N, Costa-Nunes CM, Cagnon L, Gannon PO, Abed-Maillard S, Baumgaertner P, Murray T, Letovanec I, Lazor R, Bouchaab H, Rufer N, Romano E, Michielin O, Speiser DE.

Cancer Immunol Res. 2014 Dec;2(12):1148-53. doi: 10.1158/2326-6066.CIR-14-0143. Epub 2014 Oct 2.

14.

Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab.

Meyer C, Cagnon L, Costa-Nunes CM, Baumgaertner P, Montandon N, Leyvraz L, Michielin O, Romano E, Speiser DE.

Cancer Immunol Immunother. 2014 Mar;63(3):247-57. doi: 10.1007/s00262-013-1508-5. Epub 2013 Dec 20.

PMID:
24357148
15.

Methods to assess neuroinflammation.

Monnet-Tschudi F, Defaux A, Braissant O, Cagnon L, Zurich MG.

Curr Protoc Toxicol. 2011 Nov;Chapter 12:Unit12.19. doi: 10.1002/0471140856.tx1219s50.

PMID:
22058053
16.

Design, synthesis and biological activity of original pyrazolo-pyrido-diazepine, -pyrazine and -oxazine dione derivatives as novel dual Nox4/Nox1 inhibitors.

Gaggini F, Laleu B, Orchard M, Fioraso-Cartier L, Cagnon L, Houngninou-Molango S, Gradia A, Duboux G, Merlot C, Heitz F, Szyndralewiez C, Page P.

Bioorg Med Chem. 2011 Dec 1;19(23):6989-99. doi: 10.1016/j.bmc.2011.10.016. Epub 2011 Oct 17.

PMID:
22041175
17.

JNJ-26070109 [(R)4-bromo-N-[1-(2,4-difluoro-phenyl)-ethyl]-2-(quinoxaline-5-sulfonylamino)-benzamide]: a novel, potent, and selective cholecystokinin 2 receptor antagonist with good oral bioavailability.

Morton MF, Barrett TD, Freedman J, Li L, Rizzolio MC, Prendergast CE, Wu X, Moreno V, Pyati J, Figueroa K, Cagnon L, Lagaud G, Ver Donck L, Ghoos E, Allison B, Rabinowitz MH, Shankley NP.

J Pharmacol Exp Ther. 2011 Jul;338(1):328-36. doi: 10.1124/jpet.110.178483. Epub 2011 Apr 14.

PMID:
21493750
18.

Benzimidazole-2-pyrazole HIF Prolyl 4-Hydroxylase Inhibitors as Oral Erythropoietin Secretagogues.

Rosen MD, Venkatesan H, Peltier HM, Bembenek SD, Kanelakis KC, Zhao LX, Leonard BE, Hocutt FM, Wu X, Palomino HL, Brondstetter TI, Haugh PV, Cagnon L, Yan W, Liotta LA, Young A, Mirzadegan T, Shankley NP, Barrett TD, Rabinowitz MH.

ACS Med Chem Lett. 2010 Oct 5;1(9):526-9. doi: 10.1021/ml100198y. eCollection 2010 Dec 9.

19.

Disproportionation of thermoelectric bismuth telluride nanowires as a result of the annealing process.

Lee J, Berger A, Cagnon L, Gösele U, Nielsch K, Lee J.

Phys Chem Chem Phys. 2010 Dec 14;12(46):15247-50. doi: 10.1039/c0cp00749h. Epub 2010 Nov 2.

PMID:
21046022
20.

First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis.

Laleu B, Gaggini F, Orchard M, Fioraso-Cartier L, Cagnon L, Houngninou-Molango S, Gradia A, Duboux G, Merlot C, Heitz F, Szyndralewiez C, Page P.

J Med Chem. 2010 Nov 11;53(21):7715-30. doi: 10.1021/jm100773e.

PMID:
20942471
21.

Microwave circulator based on ferromagnetic nanowires in an alumina template.

Darques M, De la Torre Medina J, Piraux L, Cagnon L, Huynen I.

Nanotechnology. 2010 Apr 9;21(14):145208. doi: 10.1088/0957-4484/21/14/145208. Epub 2010 Mar 16.

PMID:
20234085
22.

CNTF protects oligodendrocytes from ammonia toxicity: intracellular signaling pathways involved.

Cagnon L, Braissant O.

Neurobiol Dis. 2009 Jan;33(1):133-42. doi: 10.1016/j.nbd.2008.09.025. Epub 2008 Oct 18.

23.

Tuning the crystallinity of thermoelectric Bi(2)Te(3) nanowire arrays grown by pulsed electrodeposition.

Lee J, Farhangfar S, Lee J, Cagnon L, Scholz R, Gösele U, Nielsch K.

Nanotechnology. 2008 Sep 10;19(36):365701. doi: 10.1088/0957-4484/19/36/365701. Epub 2008 Jul 28.

PMID:
21828882
24.

Role of caspases, calpain and cdk5 in ammonia-induced cell death in developing brain cells.

Cagnon L, Braissant O.

Neurobiol Dis. 2008 Nov;32(2):281-92. doi: 10.1016/j.nbd.2008.07.012. Epub 2008 Jul 29.

25.

Enhanced fluid flow through nanoscale carbon pipes.

Whitby M, Cagnon L, Thanou M, Quirke N.

Nano Lett. 2008 Sep;8(9):2632-7. doi: 10.1021/nl080705f. Epub 2008 Aug 5. Erratum in: Nano Lett. 2009 Jul;9(7):2802.

PMID:
18680352
26.

Ammonium alters creatine transport and synthesis in a 3D culture of developing brain cells, resulting in secondary cerebral creatine deficiency.

Braissant O, Cagnon L, Monnet-Tschudi F, Speer O, Wallimann T, Honegger P, Henry H.

Eur J Neurosci. 2008 Apr;27(7):1673-85. doi: 10.1111/j.1460-9568.2008.06126.x.

PMID:
18380667
27.

Hyperammonemia-induced toxicity for the developing central nervous system.

Cagnon L, Braissant O.

Brain Res Rev. 2007 Nov;56(1):183-97. Epub 2007 Aug 15. Review.

PMID:
17881060
28.

Rapid assessment of anti-HIV siRNA efficacy using PCR-derived Pol III shRNA cassettes.

Scherer LJ, Yildiz Y, Kim J, Cagnon L, Heale B, Rossi JJ.

Mol Ther. 2004 Sep;10(3):597-603.

29.

Application of the trak-C HCV core assay for monitoring antiviral activity in HCV replication systems.

Cagnon L, Wagaman P, Bartenschlager R, Pietschmann T, Gao T, Kneteman NM, Tyrrell DL, Bahl C, Niven P, Lee S, Simmen KA.

J Virol Methods. 2004 Jun 1;118(1):23-31.

PMID:
15158065
30.

A role of melanin-concentrating hormone producing neurons in the central regulation of paradoxical sleep.

Verret L, Goutagny R, Fort P, Cagnon L, Salvert D, Léger L, Boissard R, Salin P, Peyron C, Luppi PH.

BMC Neurosci. 2003 Sep 9;4:19.

31.
32.
33.

Ribozyme-mediated inhibition of HIV 1 suggests nucleolar trafficking of HIV-1 RNA.

Michienzi A, Cagnon L, Bahner I, Rossi JJ.

Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):8955-60.

34.
35.

Virion encapsidation of tRNA(3Lys)-ribozyme chimeric RNAs inhibits HIV infection.

Westaway SK, Cagnon L, Chang Z, Li S, Li H, Larson GP, Zaia JA, Rossi JJ.

Antisense Nucleic Acid Drug Dev. 1998 Jun;8(3):185-97.

PMID:
9669656
36.

Retroviral delivery and anti-HIV testing of hammerhead ribozymes.

Cagnon L, Rossi J.

Methods Mol Biol. 1997;74:451-7. No abstract available.

PMID:
9204460
37.

Protection of a T-cell line from human immunodeficiency virus replication by the stable expression of a short antisense RNA sequence carried by a shuttle RNA molecule.

Cagnon L, Cucchiarini M, Lefebvre JC, Doglio A.

J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Aug 1;9(4):349-58.

PMID:
7541291
38.

Induction by human immunodeficiency viruses types 1 and 2 of degradation of CD4 but not of a CD4 mutant unable to bind viral envelope glycoproteins.

Cucchiarini M, Cagnon L, Giordanengo V, Doglio A, Lefebvre JC.

J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Apr 15;8(5):427-36.

PMID:
7697438
39.

Altered sialylation of CD45 in HIV-1-infected T lymphocytes.

Lefebvre JC, Giordanengo V, Doglio A, Cagnon L, Breittmayer JP, Peyron JF, Lesimple J.

Virology. 1994 Mar;199(2):265-74.

PMID:
8122360
40.

Epstein-Barr virus DNA detection in gingival tissues of patients undergoing surgical extractions.

Madinier I, Doglio A, Cagnon L, Lefèbvre JC, Monteil RA.

Br J Oral Maxillofac Surg. 1992 Aug;30(4):237-43.

PMID:
1324707
41.

Southern blot detection of human papillomaviruses (HPVs) DNA sequences in gingival tissues.

Madinier I, Doglio A, Cagnon L, Lefèbvre JC, Monteil RA.

J Periodontol. 1992 Aug;63(8):667-73.

PMID:
1324303

Supplemental Content

Loading ...
Support Center